Biomarin Pharmaceutical Inc (BMRN)
65.69
+0.69
(+1.06%)
USD |
NASDAQ |
Dec 20, 16:00
65.65
-0.04
(-0.06%)
After-Hours: 20:00
Biomarin Pharmaceutical Market Cap: 12.52B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co Inc | 248.03B |
| Biogen Inc | 21.34B |
| Pfizer Inc | 149.38B |
| Bristol-Myers Squibb Co | 116.28B |
| Moderna Inc | 15.16B |
Market Cap Related Metrics
| PE Ratio | 39.34 |
| PS Ratio | 4.686 |
| PEG Ratio | 0.3355 |
| Price to Book Value | 2.313 |
| Price to Free Cash Flow | 42.87 |
| Price | 65.69 |
| Earnings Yield | 2.54% |
| PEGY Ratio | 0.3355 |
| Operating PE Ratio | 41.29 |
| Normalized PE Ratio | 40.35 |